About LISEN IMPRINTING DIAGNOSTICS, INC
LisenID is a biotech company pioneering early cancer diagnostics using Loss of Imprinting (LOI) biomarkers and AI-driven analysis to provide accurate, actionable insights for clinicians. Their platform aims to eliminate indeterminate cancer diagnoses and improve patient outcomes.
Early-stage cancer detection using Loss of Imprinting (LOI) biomarkersAI-driven analysis for visual identification of carcinogenesisDiagnosis for multiple cancer types including lung, breast, and skin cancerUtilization of routine biopsy samples for seamless workflow integrationHigh diagnostic accuracy (up to 95%) in 10,000+ cases
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to LISEN IMPRINTING DIAGNOSTICS, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.